|
A Circulating Biomarker for use in Monitoring Metastatic Breast Cancer
|
1R43CA210817-01A1
|
$152,589
|
|
SERRERO, GINETTE
|
A AND G PHARMACEUTICAL, INC.
|
|
Persistent HPV Infection in Women at Risk for Cervix Cancer
|
5U01CA078527-20
|
$581,591
|
|
BURK, ROBERT
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy
|
5R01CA178394-04
|
$346,525
|
|
GAVATHIOTIS, EVRIPIDIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Proton-coupled folate/antifolate transport
|
5R01CA082621-20
|
$483,169
|
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The role of tunneling nanotubes as a novel mode of tumor cell-macrophage communication
|
5F99CA212451-02
|
$44,044
|
|
HANNA, SAMER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Training of Surgeons for Studies of the Tumor Microenvironment
|
5T32CA200561-03
|
$277,522
|
|
MICHLER, ROBERT
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Tumor expressed B7x accelerates disease and is a novel target for immunotherapy
|
5F31CA183493-04
|
$49,044
|
|
OHAEGBULAM, KIM
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Nemours NCI Community Oncology Research Program (NCORP)
|
5UG1CA189958-04
|
$388,215
|
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
Therapeutic TRPA1 Mechanism-Based Treatment of Chemotherapeutic-Induced Neuropathic Pain
|
1R43CA210759-01A1
|
$291,147
|
|
HERZ, JEFF
|
ALGOMEDIX, INC.
|
|
A NOVEL SMALL MOLECULE CX3CR1 ANTAGONIST HALTS METASTASIS
|
2R44CA183362-02A1
|
$822,075
|
|
SALVINO, JOSEPH
|
ALLIANCE DISCOVERY, INC.
|
|
Integrative Molecular Epidemiology Workshop
|
5R25CA174664-05
|
$249,213
|
|
SELLERS, THOMAS
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Development of a Pharmacoprotector for Platinum Toxicities
|
1R43CA206705-01A1
|
$225,000
|
|
CHIEN, HUAN-CHIEH
|
APRICITY THERAPEUTICS, INC.
|
|
Exploiting the immune response to detect pathogen-induced cancers
|
5R01CA199948-03
|
$436,974
|
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Charge sensitive optical detection for high-throughput study of small molecules
|
5R33CA202834-02
|
$389,677
|
|
TAO, NONGJIAN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
TREM-1 and Its Implications to Cancer
|
5R01CA172230-04
|
$315,400
|
|
HORUZSKO, ANATOLIJ
|
AUGUSTA UNIVERSITY
|
|
Role of SLC13A3 in Renal Cell Carcinoma
|
5F31CA210612-02
|
$33,744
|
|
JORDAN, ANDRE
|
AUGUSTA UNIVERSITY
|
|
Role of heat shock transcription factor HSF1 in tumoroginesis
|
5R01CA062130-22
|
$556,510
|
|
MIVECHI, NAHID
|
AUGUSTA UNIVERSITY
|
|
PNNL Proteome Characterization Center
|
5U24CA210955-02
|
$1,091,415
|
|
LIU, TAO
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
Bay Area Tumor Institute NCORP
|
5UG1CA189817-04
|
$690,000
|
|
BAILEY, LISA
|
BAY AREA TUMOR INSTITUTE
|
|
High Resolution Microendoscopy for the Management of Esophageal Neoplasia
|
5R01CA181275-04
|
$1,088,646
|
|
ANANDASABAPATHY, SHARMILA
|
BAYLOR COLLEGE OF MEDICINE
|
|
ALK causes TGF-beta insensitivity in lung cancer cells
|
5R21CA209007-02
|
$206,843
|
|
FENG, XIN-HUA
|
BAYLOR COLLEGE OF MEDICINE
|
|
MECHANISMS OF AR-ER COLLABORATION IN HORMONE RESISTANCE AND METASTASIS OF BREAST CANCER
|
1R01CA207270-01A1
|
$362,569
|
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer
|
5R01CA072038-19
|
$320,963
|
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Epigenomic reprogramming driven by mutant ER? in metastatic breast cancer
|
5F31CA210385-02
|
$43,993
|
|
GATES, LEAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Germ Cell Gene TDRD1 As A Novel Prostate Cancer Biomarker
|
1R01CA211861-01A1
|
$362,569
|
|
HE, BIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
In Vivo Drug Testing of Pediatric CNS Tumors Using Patient Derived Orthotopic Xenograft Models
|
5U01CA199288-03
|
$578,693
|
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational control of EMT by the CELF1 RNA Binding Protein
|
5R01CA190467-03
|
$362,569
|
|
NEILSON, JOEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Gut L-Histidine Metabolism and Histamine Signaling in Colonic Neoplasia
|
5U01CA170930-05
|
$452,105
|
|
VERSALOVIC, JAMES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Drugging the Undruggable Coactivators using Small Molecule Inhibitors
|
1R01CA207701-01A1
|
$427,784
|
|
WANG, JIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Osteoclast-independent mechanisms of early-stage bone colonization of breast canc
|
5R01CA183878-04
|
$324,738
|
|
ZHANG, XIANG
|
BAYLOR COLLEGE OF MEDICINE
|
|
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC
|
5U24CA210954-02
|
$973,045
|
|
ZHANG, BING
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
|
2R01CA155769-06A1
|
$410,877
|
|
BADIE, BEHNAM
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Preparing Oncology Advanced Practice Nurses as Generalists in Palliative Care
|
1R25CA217270-01
|
$310,771
|
|
FERRELL, BETTY
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Improving Patient-Centered Communication and Cancer Care
|
5R25CA174627-04
|
$304,082
|
|
FERRELL, BETTY
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Optimizing Busulfan: Efficacy Toxicity and Pharmacometabolomics
|
5R01CA182963-05
|
$515,038
|
|
MCCUNE, JEANNINE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-04
|
$108,798
|
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Combating Resistance to Antiangiogenic Therapy in Renal Cell Carcinoma
|
5R01CA196996-03
|
$398,025
|
|
BHATT, RUPAL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Investigation and functional characterization of new drivers of mesenchymal tumorigenesis.
|
5K99CA212200-02
|
$102,130
|
|
GUARNERIO, JLENIA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Basic and Translational studies of Ras-mutant colorectal cancer
|
5R01CA178017-04
|
$359,556
|
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
|
5U01CA199252-03
|
$1,041,188
|
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A National Curriculum in Cancer Genomics for Residents and Medical Students
|
2R25CA168544-06
|
$255,425
|
|
HASPEL, RICHARD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Cohesin Mutations in Acute Myelogenous Leukemia
|
1R01CA204231-01A1
|
$391,588
|
|
RAO, SRIDHAR
|
BLOODCENTER OF WISCONSIN, INC.
|
|
Discovery and targeting of apoptosis resistance mechanisms in high-risk T-ALL
|
5R01CA193651-03
|
$446,954
|
|
GUTIERREZ, ALEJANDRO
|
BOSTON CHILDREN'S HOSPITAL
|
|
Development of novel selective Rac inhibitors for refractory leukemias
|
5R01CA202756-02
|
$603,034
|
|
WILLIAMS, DAVID
|
BOSTON CHILDREN'S HOSPITAL
|
|
Molecular Mechanisms Regulating the Alternative Lengthening of Telomeres Pathway
|
5R01CA201446-02
|
$376,294
|
|
FLYNN, RACHEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
PAX3 pathways in melanoma
|
5R01CA184001-04
|
$376,389
|
|
LANG, DEBORAH
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer
|
5U01CA187508-03
|
$590,572
|
|
PALMER, JULIE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Enzyme-instructed self-assembly for molecular anticancer nanomedicines
|
5R01CA142746-08
|
$368,145
|
|
XU, BING
|
BRANDEIS UNIVERSITY
|
|
The Women's Health Study: Infrastructure Support for Continued Cohort Follow-up
|
5UM1CA182913-04
|
$835,161
|
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Impact of aging on prostate cancer with TMPRSS2-ETS gene fusion
|
5UH2CA213392-02
|
$44,999
|
|
LI, ZHE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Contraception and Reproduction Research for this search: $3,536,204
|